393 results
8-K
EX-3.1
DMKPQ
DMK Pharmaceuticals Corp
23 Jan 24
Material Modifications to Rights of Security Holders
5:22pm
, and the time and method of giving the same, shall in the absence of fraud, be prima facie evidence of the facts therein contained.
(d) Methods of Notice
8-K
EX-10.3
qqo7eu3hxws4
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-10.4
rzae wd7g4iyx31y
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-10.1
jxz5asv w6gj268rygki
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
8-K
EX-10.2
bq0tyq 79hd52e6p
19 Oct 23
Entry into a Material Definitive Agreement
5:07pm
DEFC14A
0ydi26p re4v
12 Oct 23
Proxy in contested solicitation
4:22pm
PREC14A
4l457azfbw3o3
2 Oct 23
Preliminary proxy with contested solicitation
4:49pm
8-K
EX-3.2
cwnggfj0ptggm yu
8 Sep 23
Adamis Pharmaceuticals Changes Name to DMK Pharmaceuticals to Reflect New Strategic Focus
4:50pm
8-K
EX-10.1
grknsnxkxhz8rl8q
29 Aug 23
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
qflqsqdjwl 45rq
3 Aug 23
Adamis Pharmaceuticals Announces Pricing of $8.0 Million Public Offering
4:59pm
424B4
i80fk7lg0j18veu
3 Aug 23
Prospectus supplement with pricing info
4:55pm